A citation-based method for searching scientific literature

Nattaphong Rattanavirotkul, Kristina Kirschner, Tamir Chandra. Cell Mol Life Sci 2021
Times Cited: 2







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Glioblastoma Stem Cells: Driving Resilience through Chaos.
Briana C Prager, Shruti Bhargava, Vaidehi Mahadev, Christopher G Hubert, Jeremy N Rich. Trends Cancer 2020
33
50

Genetic modification of mesenchymal stem cells to express a single-chain antibody against EGFRvIII on the cell surface.
Irina V Balyasnikova, Rosa Franco-Gou, J Michael Mathis, Maciej S Lesniak. J Tissue Eng Regen Med 2010
22
50

Stem cell-based therapy for malignant glioma.
Daniel Bexell, Andreas Svensson, Johan Bengzon. Cancer Treat Rev 2013
54
50

Strategies for enhancing intratumoral spread of oncolytic adenoviruses.
Nasser Hashemi Goradel, Babak Negahdari, Sajjad Ghorghanlu, Samira Jahangiri, Arash Arashkia. Pharmacol Ther 2020
5
50


Mesenchymal stem cell carriers enhance antitumor efficacy of oncolytic adenoviruses in an immunocompetent mouse model.
Esther Rincón, Teresa Cejalvo, Deepak Kanojia, Arantzazu Alfranca, Miguel Ángel Rodríguez-Milla, Raul Andrés Gil Hoyos, Yu Han, Lingjiao Zhang, Ramón Alemany, Maciej S Lesniak,[...]. Oncotarget 2017
29
50

Umbilical cord-derived mesenchymal stromal/stem cells expressing IL-24 induce apoptosis in gliomas.
Shaochen Fan, Huasong Gao, Wei Ji, Fengwei Zhu, Lingzheng Sun, Yuankun Liu, Siming Zhang, Yanran Xu, Yaohua Yan, Yilu Gao. J Cell Physiol 2020
7
50

TGF-β suppresses type 2 immunity to cancer.
Ming Liu, Fengshen Kuo, Kristelle J Capistrano, Davina Kang, Briana G Nixon, Wei Shi, Chun Chou, Mytrang H Do, Efstathios G Stamatiades, Shengyu Gao,[...]. Nature 2020
31
50

Role of PI3K/AKT pathway in cancer: the framework of malignant behavior.
Ningni Jiang, Qijie Dai, Xiaorui Su, Jianjiang Fu, Xuancheng Feng, Juan Peng. Mol Biol Rep 2020
58
50

Use of genetically engineered stem cells for glioma therapy.
Hiroki Namba, Hiroshi Kawaji, Tomohiro Yamasaki. Oncol Lett 2016
19
50

Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors.
Matus Studeny, Frank C Marini, Richard E Champlin, Claudia Zompetta, Isaiah J Fidler, Michael Andreeff. Cancer Res 2002
705
50

Systemic delivery of HER2-retargeted oncolytic-HSV by mesenchymal stromal cells protects from lung and brain metastases.
Valerio Leoni, Valentina Gatta, Arianna Palladini, Giordano Nicoletti, Dario Ranieri, Massimiliano Dall'Ora, Valentina Grosso, Martina Rossi, Francesco Alviano, Laura Bonsi,[...]. Oncotarget 2015
40
50

PTEN expression by an oncolytic herpesvirus directs T-cell mediated tumor clearance.
Luke Russell, Jessica Swanner, Alena Cristina Jaime-Ramirez, Yufeng Wang, Alex Sprague, Yeshavanth Banasavadi-Siddegowda, Ji Young Yoo, Gina M Sizemore, Raleigh Kladney, Jianying Zhang,[...]. Nat Commun 2018
18
50

Hitting the nail on the head: combining oncolytic adenovirus-mediated virotherapy and immunomodulation for the treatment of glioma.
Wojciech K Panek, J Robert Kane, Jacob S Young, Aida Rashidi, Julius W Kim, Deepak Kanojia, Maciej S Lesniak. Oncotarget 2017
17
50

The PI3K Pathway in Human Disease.
David A Fruman, Honyin Chiu, Benjamin D Hopkins, Shubha Bagrodia, Lewis C Cantley, Robert T Abraham. Cell 2017
713
50

The Korean Society for Neuro-Oncology (KSNO) Guideline for Glioblastomas: Version 2018.01.
Young Zoon Kim, Chae Yong Kim, Jaejoon Lim, Kyoung Su Sung, Jihae Lee, Hyuk Jin Oh, Seok Gu Kang, Shin Hyuk Kang, Doo Sik Kong, Sung Hwan Kim,[...]. Brain Tumor Res Treat 2019
7
50


Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastoma.
Junfei Zhao, Andrew X Chen, Robyn D Gartrell, Andrew M Silverman, Luis Aparicio, Tim Chu, Darius Bordbar, David Shan, Jorge Samanamud, Aayushi Mahajan,[...]. Nat Med 2019
208
50


The construction and characterization of a novel adenovirus vector of artificial microRNA targeting EGFR.
Ping Chen, Shou-De Zhang, Yi Lin, Jiang Cao, Jia Chen, Bei-Bei Yang. Int J Clin Exp Pathol 2019
3
50

Bi-specific molecule against EGFR and death receptors simultaneously targets proliferation and death pathways in tumors.
Yanni Zhu, Nicole Bassoff, Clemens Reinshagen, Deepak Bhere, Michal O Nowicki, Sean E Lawler, Jérémie Roux, Khalid Shah. Sci Rep 2017
18
50


First-in-Human, First-in-Child Trial of Autologous MSCs Carrying the Oncolytic Virus Icovir-5 in Patients with Advanced Tumors.
David Ruano, José A López-Martín, Lucas Moreno, Álvaro Lassaletta, Francisco Bautista, Maitane Andión, Carmen Hernández, África González-Murillo, Gustavo Melen, Ramón Alemany,[...]. Mol Ther 2020
23
50

Oncolytic Viruses: Exploiting Cancer's Deal with the Devil.
Larissa A Pikor, John C Bell, Jean-Simon Diallo. Trends Cancer 2015
36
50

Cytotoxicity of nanoparticles.
Nastassja Lewinski, Vicki Colvin, Rebekah Drezek. Small 2008
50

Viral oncolytic immunotherapy in the war on cancer: Infection control considerations.
Elizabeth V Robilotti, Asmita Kumar, Michael S Glickman, Mini Kamboj. Infect Control Hosp Epidemiol 2019
5
50

Mesenchymal stem cells used as carrier cells of oncolytic adenovirus results in enhanced oncolytic virotherapy.
Khaphetsi Joseph Mahasa, Lisette de Pillis, Rachid Ouifki, Amina Eladdadi, Philip Maini, A-Rum Yoon, Chae-Ok Yun. Sci Rep 2020
17
50

Cancer immunotherapy via targeted TGF-β signalling blockade in TH cells.
Shun Li, Ming Liu, Mytrang H Do, Chun Chou, Efstathios G Stamatiades, Briana G Nixon, Wei Shi, Xian Zhang, Peng Li, Shengyu Gao,[...]. Nature 2020
35
50

Intraarterial delivery of virotherapy for glioblastoma.
Visish M Srinivasan, Frederick F Lang, Peter Kan. Neurosurg Focus 2021
4
50

DOTAP (and other cationic lipids): chemistry, biophysics, and transfection.
Dmitri Simberg, Sarah Weisman, Yeshayahu Talmon, Yechezkel Barenholz. Crit Rev Ther Drug Carrier Syst 2004
146
50

HSV-TK/GCV cancer suicide gene therapy by a designed recombinant multifunctional vector.
Yuhua Wang, Brenda F Canine, Arash Hatefi. Nanomedicine 2011
26
50

Discovery and saturation analysis of cancer genes across 21 tumour types.
Michael S Lawrence, Petar Stojanov, Craig H Mermel, James T Robinson, Levi A Garraway, Todd R Golub, Matthew Meyerson, Stacey B Gabriel, Eric S Lander, Gad Getz. Nature 2014
50

Impaired Fas response and autoimmunity in Pten+/- mice.
A Di Cristofano, P Kotsi, Y F Peng, C Cordon-Cardo, K B Elkon, P P Pandolfi. Science 1999
424
50

Nanoparticle delivery of cancer drugs.
Andrew Z Wang, Robert Langer, Omid C Farokhzad. Annu Rev Med 2012
835
50

Targeting telomerase for cancer therapy.
Adam N Guterres, Jessie Villanueva. Oncogene 2020
10
50

Adoptive cell transfer as personalized immunotherapy for human cancer.
Steven A Rosenberg, Nicholas P Restifo. Science 2015
50

Non-virally engineered human adipose mesenchymal stem cells produce BMP4, target brain tumors, and extend survival.
Antonella Mangraviti, Stephany Y Tzeng, David Gullotti, Kristen L Kozielski, Jennifer E Kim, Michael Seng, Sara Abbadi, Paula Schiapparelli, Rachel Sarabia-Estrada, Angelo Vescovi,[...]. Biomaterials 2016
47
50


Turning up the heat on non-immunoreactive tumours: opportunities for clinical development.
María Ochoa de Olza, Blanca Navarro Rodrigo, Stefan Zimmermann, George Coukos. Lancet Oncol 2020
18
50

Human bone marrow-derived mesenchymal stem cells for intravascular delivery of oncolytic adenovirus Delta24-RGD to human gliomas.
Raymund L Yong, Naoki Shinojima, Juan Fueyo, Joy Gumin, Giacomo G Vecil, Frank C Marini, Oliver Bogler, Michael Andreeff, Frederick F Lang. Cancer Res 2009
148
50

FDA Approval Summary: Tisagenlecleucel for Treatment of Patients with Relapsed or Refractory B-cell Precursor Acute Lymphoblastic Leukemia.
Maura C O'Leary, Xiaobin Lu, Ying Huang, Xue Lin, Iftekhar Mahmood, Donna Przepiorka, Denise Gavin, Shiowjen Lee, Ke Liu, Bindu George,[...]. Clin Cancer Res 2019
59
50

The p53 pathway: positive and negative feedback loops.
Sandra L Harris, Arnold J Levine. Oncogene 2005
50

Oncolytic adenoviral vectors which employ the survivin promoter induce glioma oncolysis via a process of beclin-dependent autophagy.
Ilya V Ulasov, Mathew A Tyler, Zeng B Zhu, Yu Han, Tong-Chuan He, Maciej S Lesniak. Int J Oncol 2009
35
50


Challenges in Clinical Development of Mesenchymal Stromal/Stem Cells: Concise Review.
Ilenia Mastrolia, Elisabetta Manuela Foppiani, Alba Murgia, Olivia Candini, Anna Valeria Samarelli, Giulia Grisendi, Elena Veronesi, Edwin M Horwitz, Massimo Dominici. Stem Cells Transl Med 2019
61
50


Mesenchymal stem cells within tumour stroma promote breast cancer metastasis.
Antoine E Karnoub, Ajeeta B Dash, Annie P Vo, Andrew Sullivan, Mary W Brooks, George W Bell, Andrea L Richardson, Kornelia Polyak, Ross Tubo, Robert A Weinberg. Nature 2007
50

Human umbilical cord matrix-derived stem cells expressing interferon-β gene inhibit breast cancer cells via apoptosis.
Ching-Ju Shen, Te-Fu Chan, Chien-Chung Chen, Yi-Chiang Hsu, Cheng-Yu Long, Chung-Sheng Lai. Oncotarget 2016
9
50

IL7-IL12 Engineered Mesenchymal Stem Cells (MSCs) Improve A CAR T Cell Attack Against Colorectal Cancer Cells.
Andreas A Hombach, Ulf Geumann, Christine Günther, Felix G Hermann, Hinrich Abken. Cells 2020
16
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.